Tag

HIV testing

HSPH Forum To Explore HIV/AIDS Treatment As Prevention

By | Community, Fenway Health Newsroom, HIV/AIDS | No Comments
Since the AIDS crisis began in the early 80s, the medical community has struggled to understand how best to stop – and eventually end – HIV transmission. On December 1, The Forum at the Harvard School of Public Health will present TREATMENT AS PREVENTION: Can We Treat Our Way Out of the AIDS Epidemic? as part of their Andelot Series on Current Science Controversies. The discussion will feature a number of HIV/AIDS experts, including Dr. Kenneth Mayer, Medical Research Director and Co-Chair of The Fenway Institute. With no cure or vaccine in sight, HIV/AIDS remains a devastating epidemic – particularly 
Read More

HIV/STD Prevention and Treatment Research Update To Highlight Medical Advances On November 17

By | AIDS 2014, Events, Fenway Health Newsroom, HIV/AIDS | No Comments
30 years after the start of the AIDS epidemic, the medical research community has made great strides in improving prevention and treatment methods – and that work continues today. On November 17, Fenway Health is proud to host an HIV/STD Prevention and Treatment Research Update. This event, which occurs at least once a year, brings together some of the leading HIV/AIDS and STD authorities to share new exciting breakthroughs and research findings with the community, as well as to outline where HIV/STD prevention and treatment is headed next. During the evening, experts in the fields of HIV and STD research 
Read More

New Fenway Institute Study Explores Revolutionary Method Of HIV Prevention

By | Fenway Health Newsroom, HIV/AIDS | No Comments
The Fenway Institute is excited to announce its participation in a nationwide novel HIV prevention study called HVTN-104. This study is being conducted to test a manufactured antibody to prevent HIV.  The purpose of this study is to learn about how the antibody works, how well it works, and the side effects that people may experience when administered this antibody. This study is currently enrolling HIV-negative individuals of any gender who are between 18 and 50 years of age and in good health. The study product, VRC01, has been tested in more than 25 people in clinical trials at the 
Read More

CDC Urges Public to Start Talking, Stop HIV in New Campaign

By | Fenway Health Newsroom, HIV/AIDS | No Comments
The Centers for Disease Control and Prevention (CDC) has launched a new campaign to coincide with National Gay Men’s HIV/AIDS Awareness Day on September 27. Part of the CDC’s Act Against AIDS initiative, Start Talking. Stop HIV. is a national effort to promote frank and honest discussions around HIV testing, safe sex, pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), and antiretroviral (ARV) treatments. According to the CDC’s site, the campaign’s mission is to “reduce new HIV infections among gay, bisexual and other men who have sex with men by encouraging open discussion about a range of HIV prevention strategies and related 
Read More

Prevention Update Spring 2013: Teamwork with Our Local and National Partners

By | Education, HIV/AIDS, HIV/AIDS, The Fenway Institute | No Comments
May and June were busy months for Fenway’s HIV Counseling, Testing and Screening program.  Working in conjunction with some of our local and national partners, we participated in several events designed to raise awareness of HIV/AIDS and improve access to condoms and HIV testing. Condoms On June 26, Victory Programs and Fenway Health presented Condom Summit 2013: Condoms as Community Care.  The event was in response to a the reprioritization of condom distribution from the US Centers for Disease Control and Prevention (CDC) based on the National AIDS Strategy, and a local push from the Massachusetts Department of Public Health 
Read More